Objective
CHARACTERIZIATION AND UTILISATION OF TWO NEW FILARIAL MODELS FOR INVESTIGATIONS OF IMMUNITY CHEMOTHERAPY AND PATHOLGY. THIS WORK IS CONCERNED WITH PREVENTION AND TREATMENT OF FILARIAL INFECTIONS AND IN PARTICULAR ANCHOCERIAS. ATTENTION WILL FOCUS ON THE INTERPLAY BETWEEN IMMUNITY, PATHOLOGY AND DRUG TREATMENT AND N PARTICULAR IVERMECETIN. KNOWLEDGE IN THIS AREA WILL BE IMPORTANT FOR THE SUCCESSFUL DEVELOPMENT AND USE OF A VACCINE. FOR THIS WORK TWO MURID MODELS WILL BE USED. FIRST LITOMOSOIDEDS SIGMODONTIS (STRAN PARIS) WHCIH CAN UDERGO COMPLETE CYCLICAL DEVELOPMENT IN IMMUUNICOMPENT MICE (MUSMUSCULUS) AND PROVIDES AN EXCELLENT OPPORTUNITY TO INVESTIGATE CELLULAR (AND HUMORAL) RESPONSES EVOKED BY A FILARIAL PARASITE IN THE BEST IMMUNOLOGICALLY CHARACTERIZED OF MAMMALIAN HOSTS. SECOND MONANEMA MARTINI WHICH PRESENTS WITH DERMAL MICROFILARIAE AND INDUCES OCULAR AND SKIN PATHOLOGY SIMILAR TO THAT SEEN IN HUMAN ONCHOCERCIASIS. THE OBJECTIVES ARE FURTHER PARASITOLIGAL CHARACTERIZATION OF THE FOLLOWING FILARIAL MODELS: L SINGMODONTIS IN MICE AND MERIONES AND M MARTINI IN LEMNISCOMY STRIATUS AND MERIONES. ASSESSMENT OF CELLULAR RESPONSES EVOKED BY L SIGMODONTIS IMMUNCOMPENTET MICE MUSMUSCULUS AND FOLLOWING VACCINATION WITH IRRADIATED IARVAE AND RECOMBINANT ANTIGENS. THIS INCLUDES AND INVESTIGATION OF THE ROLE OF THI AND TH2 T-HELPER CELL SUBSETS AND SELECTED CYCTOKINES. ASSESMENT OF THE EFFECT OF IVERMECTIN TREATMENT ON IMMUNE RESPONSE EVOKED BY L SIGMODONTIS AND M MARTINI. INCLUDING AN INVESTIGATION OF DRUG INDUCED IMMUNITY WHICH HAD BEEN OBSERVED TO FOLLOW IVERMECTIN TREATMENT IN MAN AND RODENT MODELS. THE PHARMACOKINETICS OF IVERMECITIN IN DIFFERENT RODENT MODELS WILL BE EXAMINED BEFORE AND AFTER INFECTION AND IMMUNIZATION. IDENTIFICATION OF POSSIBLE CORRELATIONS BETWEEN PARASITOLIGICAL FEATURES, DRUGS, IMMUNITY AND PATHOLOGY. THE TECHNIQUES PROCEDURES AND PERSONAL EXPERTISE REQUIRED EXIST IN THE LABOROTORIES OF THE FOUR PARTNERS. THIS PROGRAMME COMPLEMENTS OTHER COLLABORATIONS INCLUDING HUMAN FIELD STUDIES.
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciencesbasic medicineimmunologyimmunisation
- medical and health sciencesbasic medicinepharmacology and pharmacypharmaceutical drugsvaccines
- medical and health sciencesbasic medicinepathology
- medical and health sciencesbasic medicinepharmacology and pharmacypharmacokinetics
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Topic(s)
Data not availableCall for proposal
Data not availableFunding Scheme
CSC - Cost-sharing contractsCoordinator
75231 Paris
France